Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
MED

MED - Medifast Inc Stock Price, Fair Value and News

19.61USD-0.37 (-1.85%)Market Closed

Market Summary

MED
USD19.61-0.37
Market Closed
-1.85%

MED Stock Price

View Fullscreen

MED RSI Chart

MED Valuation

Market Cap

214.5M

Price/Earnings (Trailing)

3.17

Price/Sales (Trailing)

0.24

EV/EBITDA

1.16

Price/Free Cashflow

2.53

MED Price/Sales (Trailing)

MED Profitability

Operating Margin

73.15%

EBT Margin

9.70%

Return on Equity

32.12%

Return on Assets

22.38%

Free Cashflow Yield

39.48%

MED Fundamentals

MED Revenue

Revenue (TTM)

897.8M

MED Earnings

Earnings (TTM)

67.8M

Breaking Down MED Revenue

Last 7 days

-8.7%

Last 30 days

-21.5%

Last 90 days

-45.1%

Trailing 12 Months

-76.2%

How does MED drawdown profile look like?

MED Financial Health

Current Ratio

2.84

MED Investor Care

Dividend Yield

16.83%

Dividend/Share (TTM)

3.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024897.8M000
20231.5B1.4B1.2B1.1B
20221.6B1.7B1.6B1.6B
20211.1B1.3B1.4B1.5B
2020726.3M759.2M840.6M934.8M
2019568.3M638.1M688.9M713.7M
2018329.5M371.1M433.2M501.0M
2017272.8M277.4M286.0M301.6M
2016271.8M270.7M273.4M274.5M
2015279.4M276.8M273.8M272.8M
2014307.2M284.9M267.4M285.3M
2013325.7M329.2M324.7M324.1M
2012312.8M328.1M343.0M318.6M
2011271.3M282.9M291.6M298.2M
20100199.0M228.3M257.6M
2009000169.7M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Medifast Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 15, 2024
mackenzie jonathan barrett
sold (taxes)
-4,905
36.61
-134
vp, finance & cao
Mar 15, 2024
maloney james p.
sold (taxes)
-22,551
36.61
-616
chief financial officer
Mar 15, 2024
chard daniel r
sold (taxes)
-124,803
36.61
-3,409
chairman & ceo
Mar 13, 2024
maloney james p.
acquired
-
-
8,718
chief financial officer
Mar 13, 2024
mackenzie jonathan barrett
acquired
-
-
2,565
vp, finance & cao
Mar 13, 2024
chard daniel r
acquired
-
-
45,087
chairman & ceo
Mar 08, 2024
schlackman scott
sold
-159,866
39.444
-4,053
-
Mar 08, 2024
schlackman scott
acquired
35,984
27.68
1,300
-
Feb 14, 2024
chard daniel r
sold (taxes)
-288,212
52.68
-5,471
chairman & ceo
Feb 14, 2024
chard daniel r
acquired
-
-
16,486
chairman & ceo

1–10 of 50

Which funds bought or sold MED recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
2,607
9,493
10,434
-%
Jun 04, 2024
DekaBank Deutsche Girozentrale
sold off
-100
-536,000
-
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-104,000
137,000
-%
May 22, 2024
BURNEY CO/
new
-
768,852
768,852
0.03%
May 20, 2024
Virtu Financial LLC
new
-
229,000
229,000
0.02%
May 17, 2024
Plato Investment Management Ltd
unchanged
-
-3,843
5,097
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-5.15
-354,159
416,922
-%
May 16, 2024
Pineridge Advisors LLC
unchanged
-
-3,802
5,042
-%
May 16, 2024
COMERICA BANK
reduced
-3.76
-151,704
184,396
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-20.06
-851,169
712,637
-%

1–10 of 37

Are Funds Buying or Selling MED?

Are funds buying MED calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MED
No. of Funds

Unveiling Medifast Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
renaissance technologies llc
6.96%
757,610
SC 13G/A
Feb 13, 2024
vanguard group inc
15.49%
1,686,957
SC 13G/A
Jan 22, 2024
blackrock inc.
16.6%
1,805,021
SC 13G/A
Feb 13, 2023
renaissance technologies llc
5.78%
632,110
SC 13G/A
Feb 09, 2023
vanguard group inc
15.35%
1,676,883
SC 13G/A
Jan 26, 2023
blackrock inc.
16.9%
1,847,773
SC 13G/A
Jan 20, 2023
blackrock inc.
16.9%
1,847,773
SC 13G/A
Feb 11, 2022
renaissance technologies llc
6.87%
797,610
SC 13G/A
Feb 10, 2022
vanguard group inc
12.91%
1,499,306
SC 13G/A
Jan 27, 2022
blackrock inc.
17.2%
1,995,911
SC 13G/A

Recent SEC filings of Medifast Inc

View All Filings
Date Filed Form Type Document
May 08, 2024
ARS
ARS
Apr 29, 2024
8-K
Current Report
Apr 29, 2024
10-Q
Quarterly Report
Apr 26, 2024
DEFA14A
DEFA14A
Apr 26, 2024
DEF 14A
DEF 14A
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading
Mar 15, 2024
4
Insider Trading
Mar 15, 2024
4
Insider Trading

Peers (Alternatives to Medifast Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
24.1B
3.2B
7.83% 21.05%
54.61
7.61
14.49% 15.15%
10.5B
4.1B
1.34% 8.29%
20.03
2.55
2.27% 6.78%
MID-CAP
5.9B
2.5B
-6.27% 9.03%
71.36
2.38
17.68% 19.79%
2.7B
1.8B
-1.67% 13.21%
15.01
1.53
6.73% 101.10%
2.3B
940.3M
2.81% -16.80%
30.92
2.49
6.48% -23.25%
SMALL-CAP
414.5M
390.5M
0.85% -1.30%
13.14
1.06
6.25% -6.74%
214.5M
897.8M
-21.52% -76.17%
3.17
0.24
-41.32% -52.20%
99.1M
854.2M
-30.94% -81.34%
-0.29
0.12
-13.19% 7.03%
10.6M
209.3M
-23.20% -78.57%
-2.15
0.05
-14.10% 89.07%

Medifast Inc News

Latest updates
AOL15 Jun 202405:01 am
StreetInsider.com30 Apr 202407:00 am
InvestorPlace30 Apr 202407:00 am
Yahoo Finance30 Apr 202407:00 am
Seeking Alpha3 months ago

Medifast Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-8.5%175191236296349337390453418378413394341265271220178171190187166
Cost Of Revenue-4.4%47.0050.0058.0085.0010310410813211510010610092.0066.0067.0061.0043.0043.0047.0046.0041.00
Gross Profit-10.0%127141177211246234283322302278307294249199204159135128143141125
  S&GA Expenses-10.1%119133152172193201235273247231252232196161159131112109123113100
EBITDA Margin-15.5%0.11*0.13*0.13*0.13*0.13*0.12*0.13*0.13*0.14*0.15*0.15*0.16*---------
Income Taxes-13.2%3.004.003.009.0013.006.0012.0010.0013.0013.0013.0014.0012.0010.0010.006.005.00-0.905.006.004.00
Earnings Before Taxes18.2%12.0010.0027.0039.0053.0032.0048.0049.0055.0047.0055.0061.0053.0038.0045.0028.0024.0019.0021.0028.0025.00
EBT Margin-19.3%0.10*0.12*0.12*0.13*0.12*0.12*0.12*0.12*0.14*0.14*0.15*0.15*---------
Net Income37.8%8.006.0023.0030.0040.0027.0036.0039.0042.0034.0042.0047.0041.0028.0034.0022.0018.0020.0016.0021.0021.00
Net Income Margin-18.6%0.08*0.09*0.10*0.10*0.09*0.09*0.09*0.09*0.10*0.11*0.11*0.12*---------
Free Cashflow-43.2%5.0010.0028.0041.0062.0043.0054.0041.0041.00-19.085.0013.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-2.3%303310320319322316326341421398371364326276261232202195199213210
  Current Assets-2.0%220224224229230223230243324307301304282234217191161154158172169
    Cash Equivalents3.2%97.0094.0011314712488.0070.0061.0011810415519220616415613191.0077.0081.0096.00102
  Inventory-15.2%46.0055.0058.0069.0097.0011914515718918013096.0062.0053.0042.0039.0048.0049.0052.0048.0043.00
  Net PPE-0.9%51.0051.0053.0054.0056.0057.0058.0059.0058.0056.0046.0037.0031.0028.0027.0025.0025.0026.0026.0025.0023.00
Liabilities-15.3%92.0010812713315116117621120519617517015211912111591.0090.0087.0087.0088.00
  Current Liabilities-16.4%77.0092.0011011513214115418818117016115414511111210782.0079.0078.0076.0077.00
Shareholder's Equity4.7%211201193186171155151129216202196195175157140117111105111126122
  Retained Earnings4.8%183175169164152140132129203190183185179154140119110169163156143
  Additional Paid-In Capital5.2%28.0027.0024.0022.0019.0022.0019.00-13.0012.0013.0011.009.008.005.003.000.00-12.0011.0010.00
Shares Outstanding0.4%11.0011.0011.0011.0011.0011.0011.0011.0012.0012.0012.0012.00---------
Float----1,000---2,000---3,300---1,500---1,500-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-30.8%7,28210,52229,93043,14664,05951,73955,39643,76243,673-7,45915,80020,87865,32619,82941,11457,51826,73519,15217,89714,47832,734
  Share Based Compensation-9.3%2,1712,3932,6752,5146062,9502,9632,8652,2753,2982,3002,1002,1982,5962,1001,1001,0001,0631,2001,3001,000
Cashflow From Investing74.1%-2,775-10,731-46,457-1,744-2,115-9,064-1,7681,182-1,764-11,624-10,389-6,173-878570-2,269-289706-834-952-1,098-3,444
Cashflow From Financing91.7%-1,491-17,905-18,153-17,835-25,896-24,331-45,106-102,025-28,119-31,232-42,945-28,738-22,218-13,144-13,186-17,073-13,741-22,542-32,058-18,911-8,813
  Dividend Payments-96.1%71017,97818,04317,83319,16317,92218,08118,95716,66017,01116,75016,70313,39213,29813,32413,31413,2548,7388,9098,9238,826
  Buy Backs-----3,6026,397-110,04810,0009,99926,27012,2307,500-----23,116--
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MED Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 174,739$ 348,983
Cost of sales47,447102,593
Gross profit127,292246,390
Selling, general, and administrative119,352192,879
Income from operations7,94053,511
Other income (expense)  
Interest income (expense)1,223(181)
Other income (expense)2,422(1)
Total other expense3,645(182)
Income from operations before income taxes11,58553,329
Provision for income taxes3,26913,361
Net income$ 8,316$ 39,968
Earnings per share - basic (in usd per share)$ 0.76$ 3.68
Earnings per share - diluted (in usd per share)$ 0.76$ 3.67
Weighted average shares outstanding  
Basic (in shares)10,90910,864
Diluted (in shares)10,95810,899
Cash dividends declared per share (in usd per share)$ 0$ 1.65

MED Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets  
Cash and cash equivalents$ 97,471$ 94,440
Inventories46,27354,591
Investments58,95755,601
Income taxes, prepaid5,4718,727
Prepaid expenses and other current assets11,41210,670
Total current assets219,584224,029
Property, plant and equipment - net of accumulated depreciation50,98651,467
Right-of-use assets14,53615,645
Other assets13,64814,650
Deferred tax assets4,0054,117
TOTAL ASSETS302,759309,908
Current Liabilities  
Accounts payable and accrued expenses71,22986,415
Current lease obligations5,9585,885
Total current liabilities77,18792,300
Lease obligations, net of current lease obligations14,61116,127
Total liabilities91,798108,427
Stockholders' Equity  
Common stock, par value $0.001 per share: 20,000 shares authorized; 10,937 and 10,896 issued and outstanding at March 31, 2024 and December 31, 2023, respectively1111
Additional paid-in capital27,96326,573
Accumulated other comprehensive income22248
Retained earnings182,965174,649
Total stockholders' equity210,961201,481
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$ 302,759$ 309,908
MED
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.
 CEO
 WEBSITEhttps://medifastinc.com
 INDUSTRYPersonal Services
 EMPLOYEES874

Medifast Inc Frequently Asked Questions


What is the ticker symbol for Medifast Inc? What does MED stand for in stocks?

MED is the stock ticker symbol of Medifast Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Medifast Inc (MED)?

As of Tue Jun 18 2024, market cap of Medifast Inc is 214.48 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MED stock?

You can check MED's fair value in chart for subscribers.

What is the fair value of MED stock?

You can check MED's fair value in chart for subscribers. The fair value of Medifast Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Medifast Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MED so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Medifast Inc a good stock to buy?

The fair value guage provides a quick view whether MED is over valued or under valued. Whether Medifast Inc is cheap or expensive depends on the assumptions which impact Medifast Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MED.

What is Medifast Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, MED's PE ratio (Price to Earnings) is 3.17 and Price to Sales (PS) ratio is 0.24. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MED PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Medifast Inc's stock?

In the past 10 years, Medifast Inc has provided -0.028 (multiply by 100 for percentage) rate of return.